
Toujeo SoloStar300 IU/ml
Synovia Pharma PLC
Insulin Glargine is a long-acting (basal) insulin analog indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus.
Insulin Glargine is a long-acting (basal) insulin analog indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus.
Insulin Glargine is not indicated for the treatment of diabetic ketoacidosis; a rapid-acting intravenous insulin is required for that condition.
Dosage of Insulin Glargine must always be individualized and adjusted by a qualified physician based on the patient's blood glucose targets, meal pattern, activity level, and results of self-monitoring of blood glucose. There is no fixed universal dose.
| Indication | Typical starting guidance |
|---|---|
| Type 1 diabetes (adults and children) | Approximately one-third of the total daily insulin requirement is given as Insulin Glargine; the remainder is given as short- or rapid-acting insulin with meals, individualized by the physician. |
| Type 2 diabetes (insulin-naive adults) | A common starting dose is 0.2 units/kg or up to 10 units once daily, subsequently titrated by the physician based on glucose monitoring. |
| Switching from other insulin regimens | Dose conversion (e.g., from NPH insulin or other basal insulins) must be done under close medical supervision with more frequent glucose monitoring during the transition period. |
Insulin Glargine is given once daily (occasionally split into two doses on physician advice) by subcutaneous injection at the same time each day, into the abdomen, thigh, or upper arm, with rotation of injection sites. It must not be given intravenously or used in an insulin infusion pump, and must not be diluted or mixed with any other insulin or solution in the same syringe.
The most common and most serious adverse effect of Insulin Glargine is hypoglycemia, which can be severe and life-threatening (see also Precautions and Warnings).
Other reported side effects of Insulin Glargine include:
Insulin Glargine is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.